Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder Cancer
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test the safety and tolerability of an experimental
drug, Chemophase, a combination of recombinant human hyaluronidase, (an investigational
synthetic enzyme also known as rHuPH20), and mitomycin (MMC) in the treatment of superficial
bladder cancer when instilled intravesically immediately after TURBT (transurethral resection
of bladder tumor).